Home/Filings/4/0001493152-23-021751
4//SEC Filing

Huntsman Ronald Kirk 4

Accession 0001493152-23-021751

CIK 0001716166other

Filed

Jun 19, 8:00 PM ET

Accepted

Jun 20, 6:10 AM ET

Size

8.5 KB

Accession

0001493152-23-021751

Insider Transaction Report

Form 4
Period: 2023-06-15
Huntsman Ronald Kirk
DirectorChief Executive Officer10% Owner
Transactions
  • Purchase

    Common Stock

    2023-06-15$0.50/sh+21$1157,521 total
  • Purchase

    Common Stock

    2023-06-16$0.54/sh+10,000$5,40067,521 total
  • Purchase

    Common Stock

    2023-06-16$0.53/sh+5,000$2,65072,521 total
Holdings
  • Common Stock

    (indirect: See footnote)
    1,740,000
Footnotes (1)
  • [F1]Shares held by Coronado V Partners, LLC, of which the reporting person is a member and manager.

Documents

1 file

Issuer

Vivos Therapeutics, Inc.

CIK 0001716166

Entity typeother

Related Parties

1
  • filerCIK 0001835498

Filing Metadata

Form type
4
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 6:10 AM ET
Size
8.5 KB